Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
02/2002
02/13/2002CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them
02/13/2002CN1335839A Bis-sulfonamides
02/13/2002CN1335838A Pyrimidine compounds
02/13/2002CN1335837A Imidazole compounds and medicinal use thereof
02/13/2002CN1335836A Tricyclic pyrazole derivatives
02/13/2002CN1335314A Process for producing 2-substituted benzo [b] thiazoles intermediate
02/13/2002CN1079097C Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
02/13/2002CN1079096C Arylsulfonylimidazolone derivatives as antitumor agent
02/12/2002US6346630 3-Arylbenzofuranones as stabilizers
02/12/2002US6346625 Protein kinase inhibitors
02/12/2002US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
02/12/2002US6346540 1-(1,2-disubstituted pipeidinyl)-4-substituted piperidine derivatives
02/12/2002US6346527 Guanidine derivatives
02/12/2002US6346503 Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides
02/12/2002CA2221190C Novel substituted taxanes and pharmaceutical compositions containing them
02/12/2002CA2094702C Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
02/12/2002CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present
02/07/2002WO2002010159A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis
02/07/2002WO2002010157A1 Benzofuran derivatives and their use as antibacterial agents
02/07/2002WO2002010156A1 Benzofuran derivatives and their use as antibacterial agents
02/07/2002WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002WO2002010140A2 Imidazolyl derivatives
02/07/2002WO2002010137A2 Indazole derivatives as jnk inhibitors
02/07/2002WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
02/07/2002WO2002009651A2 Fatty acid synthase inhibitors
02/07/2002WO2002009648A2 Antimicrobial biaryl compounds
02/07/2002WO2001081310A8 1-aroyl-piperidinyl benzamidines
02/07/2002WO2001060806A3 Substituted arylpyrazines
02/07/2002US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/07/2002US20020016459 Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides
02/07/2002US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc.
02/07/2002US20020016365 Nonsteroidal gestagens
02/07/2002US20020016337 Heterocyclic analgesic compounds and methods of use thereof
02/07/2002US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease
02/07/2002US20020016333 Pyrazoles and pyrazolopyrimidines having crf antagonistic activity
02/07/2002US20020016328 Corticotropin releasing factor antagonists
02/07/2002US20020016262 Free of phytotoxicity to corn and can control a broad range of cropland weeds at a low dosage
02/07/2002DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives
02/07/2002CA2418121A1 Antimicrobial biaryl compounds
02/07/2002CA2418071A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis
02/07/2002CA2417650A1 Indazole derivatives as jnk inhibitors and compositions and methods related thereto
02/07/2002CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002CA2417204A1 Imidazolyl derivatives
02/06/2002EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands
02/06/2002EP1177181A1 Substituted bicyclic compounds
02/06/2002EP1177178A1 Heterocyclically substituted benzimidazoles, the production and application thereof
02/06/2002EP1177177A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
02/06/2002EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands
02/06/2002EP1177175A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
02/06/2002EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
02/06/2002EP1177172A1 3a,4,5,9b-TETRAHYDRO-1H-BENZ e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS
02/06/2002EP1176959A1 Novel prolines as antimicrobial agents
02/06/2002EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/06/2002EP0882024B1 Retroviral protease inhibiting compounds
02/06/2002EP0843551B1 Endothelin receptor antagonists
02/06/2002EP0734386B1 Platelet activating factor antagonists: imidazopyridine indoles
02/06/2002CN1334812A Piperazine derivatives
02/06/2002CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/06/2002CN1078889C Non-pepitde tachykinin receptor antagonists
02/05/2002US6344570 Substituted urea derivatives as cell adhesion inhibitors
02/05/2002US6344564 Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones
02/05/2002US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
02/05/2002US6344485 Method for treating glaucoma
02/05/2002US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis
02/05/2002US6344468 Substituted isoindolones and their use as cyclic GMP modulators in medicaments
02/05/2002US6344463 Skin disorders, acne
02/05/2002US6344462 Heterocyclic compounds as bradykinin antagonists
02/05/2002US6344454 Contraceptive preparations,treatment of endometriosis, gynecological disorders,premenstrual symptoms, male birth control, male hrt and hormone therapy and for treating andrological disease agents.
02/05/2002US6344453 Insecticidal heterocyclic compounds
02/05/2002US6344450 Lactam compounds and their use as inhibitors of serine proteases and method
02/05/2002US6344449 Headache and morphine dependence
02/05/2002CA2217513C Pharmaceutical agents for the treatment of alzheimer's disease
02/05/2002CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists
02/05/2002CA2082074C 1h-substituted-1,2,4-triazole compounds for treatment of cardiovascular disorders
01/2002
01/31/2002WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
01/31/2002WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
01/31/2002WO2002008223A1 Indole derivatives useful for the treatment of cns disorders
01/31/2002WO2002008222A2 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
01/31/2002WO2002008220A1 2-thenoic acid (thiophene) derivatives having glutamate receptor antagonistic activity
01/31/2002WO2002008217A2 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
01/31/2002WO2002008215A1 Hyperpolarizable organic chromophores
01/31/2002WO2002008200A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
01/31/2002WO2002008191A1 Potassium channel inhibitors
01/31/2002WO2002008186A2 Cyclopentanoindoles, compositions containing such compounds and methods of treatment
01/31/2002WO2002008185A1 Pyrrolidine derivatives as metalloprotease inhibitors
01/31/2002WO2002008183A2 Potassium channel inhibitors
01/31/2002WO2002007673A2 Calcilytic compounds
01/31/2002WO2001040184B1 Methods for the syntheses of alfentanil, sufentanil and remifentanil
01/31/2002WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens
01/31/2002US20020013476 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
01/31/2002US20020013460 Condensed pyridine compound
01/31/2002US20020013360 Protease inhibitors
01/31/2002US20020013349 Administering drug which opens potassium channel for reducing pain
01/31/2002US20020013348 For prophylaxis and therapy of asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis, infection by HIV, delaying of the onset of AIDS
01/31/2002US20020013346 C7 ester substituted taxanes
01/31/2002US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
01/31/2002US20020013321 Used as ligands for opioid receptors, for therapy of neurological and gastrointestinal disorders
01/31/2002US20020013318 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
01/31/2002US20020013310 Inhibitors of the activity of Factor Xa such as 3-((1-(4-Aminoquinolin-7-ylmethyl)-2-oxopyrrolidin-3-(R)-yl)-( 5- chloro-1H-indol-2-ylmethyl)amino)propionic acid methyl ester
01/31/2002US20020012977 Enzymatic oxidations